Trial Profile
Pain Assessment and Quality of Life in Back Pain Patients: Role of Milnacipran.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 11 Jan 2017 Status changed from discontinued to withdrawn prior to enrolment.
- 25 Oct 2016 Status changed from recruiting to discontinued as per the company decision.
- 20 Oct 2010 New trial record